iOnctura's DIONE-01 study examines the PI3Kδ inhibitor IOA-244 in metastatic uveal melanoma and other tumor types. Part A of the study assessed safety and dosage, while Part B focuses on IOA-244's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results